|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$48,301.50 |
2.60% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$46,344.21 |
2.49% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$43,618.88 |
2.34% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$42,927.68 |
2.31% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$42,505.50 |
2.28% |
| Waters Corporation |
WAT |
941848103 |
121 |
$42,409.29 |
2.28% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$40,966.20 |
2.20% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$40,782.21 |
2.19% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$39,747.75 |
2.14% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$39,839.65 |
2.14% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$39,693.11 |
2.13% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$39,352.50 |
2.11% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$39,000.14 |
2.10% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$38,809.32 |
2.09% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,556.00 |
2.07% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,543.47 |
2.07% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$38,315.00 |
2.06% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$38,259.41 |
2.06% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$38,210.05 |
2.05% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$37,984.05 |
2.04% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$37,550.97 |
2.02% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$37,333.68 |
2.01% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$37,345.78 |
2.01% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$37,284.49 |
2.00% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$37,028.75 |
1.99% |
| Steris Plc |
STE |
G8473T100 |
173 |
$36,970.10 |
1.99% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$37,007.88 |
1.99% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$36,728.73 |
1.97% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,415.34 |
1.96% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$36,324.89 |
1.95% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$36,365.67 |
1.95% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$35,658.98 |
1.92% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$35,681.64 |
1.92% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$35,510.16 |
1.91% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$35,299.68 |
1.90% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$35,216.45 |
1.89% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$34,964.41 |
1.88% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$34,738.36 |
1.87% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$34,678.91 |
1.86% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$34,458.32 |
1.85% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$34,515.18 |
1.85% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,023.59 |
1.83% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$33,498.85 |
1.80% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$33,542.22 |
1.80% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$33,121.62 |
1.78% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$32,326.18 |
1.74% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$31,863.21 |
1.71% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$31,438.40 |
1.69% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$30,645.44 |
1.65% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$22,472.24 |
1.21% |
| US Dollar |
$USD |
|
6,589 |
$6,589.19 |
0.35% |
| Japanese Yen |
$JPY |
|
44,982 |
$286.66 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|